AI Finds New Targets for Fighting Viral Infections
Researchers have developed an artificial intelligence tool to identify early-stage inhibitors for antiviral therapy. The method focuses on host-directed therapy, which targets the human body's own…
Wellness Bio Radar
Neuroscience-backed approaches to mental performance, stress resilience and cognitive optimisation.
232 articlesResearchers have developed an artificial intelligence tool to identify early-stage inhibitors for antiviral therapy. The method focuses on host-directed therapy, which targets the human body's own…
A recent review by Dr. DeBattista highlights how the standard „start low, go slow” approach clashes with the urgent need to treat major depressive disorder in patients who also have liver, kidney, or…
Millions of people now rely on artificial intelligence chatbots to navigate feelings of anxiety or depression. A recent study published in Digital Health introduces a framework to determine if these…
Researchers have discovered that targeting B-cells early in the progression of multiple sclerosis can significantly lower the frequency of relapses. A recent clinical study indicates that patients…
Inmune Bio and Quantum Computing Inc. have launched a collaboration to apply quantum computing, artificial intelligence, and data analytics to uncover new potential uses for XPro1595, the company’s…
Longeveron, a Miami-based biotech firm, has released new preprint data from its CLEAR MIND trial. The study examined 49 patients with early Alzheimer's disease. Researchers found that Longeveron's…
A pilot study in Oregon’s state‑regulated psilocybin program found that group dosing is both feasible and well tolerated among low‑income adults with depression. The trial, conducted in 2024,…
A recent study by Compass Pathways examined the economic impact of treatment‑resistant depression (TRD) and the potential of their psilocybin therapy, COMP360, to provide lasting relief. The research…
In a recent editorial, Dr. Marisa Weiss, founder and chief medical officer of Breastcancer.org, warned that while awareness of breast cancer has surged, support for patients dwindles once treatment…
Biotechnology firm invIOs has released promising clinical findings regarding its experimental cancer treatment, APN401. The study, published in the journal Molecular Therapy Oncology, details the…
Recent studies examining the effects of social media breaks on young people’s mental health have produced mixed results, leaving key questions unanswered about whether reducing screen time improves…
A new study reveals that a six-week mindfulness program incorporating nature activities significantly reduced stress and improved emotional well-being among parents and caregivers. Conducted by…